Literature DB >> 1979178

Drug-induced purposeless chewing: animal model of dyskinesia or nausea?

N M Rupniak1, S J Tye, S D Iversen.   

Abstract

Drug-induced purposeless chewing movements in rodents are often considered to represent movement disorders or dyskinesias. We have compared the ability of drugs to induce chewing and retching or emesis in squirrel monkeys; such studies are not possible in rodents, which do not vomit. Acute administration of oxotremorine (3.3-33 micrograms/kg IM), SKF38393 (1-30 mg/kg SC) or ipecacuanha (0.5-0.75 mg/kg PO) caused dose-related increases in purposeless chewing which was frequently associated with retching and emesis. Treatment with haloperidol (0.015-0.06 mg/kg IM) did not induce chewing. Rather, haloperidol decreased spontaneous chewing at doses of 0.03 and 0.06 mg/kg. Our findings indicate that at least some drug-induced oral behaviours in rodents may reflect nausea rather than dyskinesia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979178     DOI: 10.1007/bf02244098

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat.

Authors:  J D Salamone; M D Lalies; S L Channell; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  The status of late-onset vacuous chewing/perioral movements during long-term neuroleptic treatment in rodents: tardive dyskinesia or dystonia?

Authors:  J L Waddington; A G Molloy
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Induction of oral dyskinesias in naive rats by D1 stimulation.

Authors:  H Rosengarten; J W Schweitzer; A J Friedhoff
Journal:  Life Sci       Date:  1983-12-19       Impact factor: 5.037

4.  Pharmacological modification of experimental tardive dyskinesia.

Authors:  S Bárány; L M Gunne
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-08

5.  Oral dyskinesia in rats following brain lesions and neuroleptic drug administration.

Authors:  L M Gunne; J Growdon; B Glaeser
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Haloperidol-induced tardive dyskinesia in monkeys.

Authors:  L M Gunne; S Bárány
Journal:  Psychopharmacology (Berl)       Date:  1976-11-24       Impact factor: 4.530

7.  Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats.

Authors:  N M Rupniak; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia.

Authors:  R B Glassman; H N Glassman
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 9.  Acute dystonia induced by neuroleptic drugs.

Authors:  N M Rupniak; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

10.  Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.

Authors:  R E See; E D Levin; G D Ellison
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more
  3 in total

1.  Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets.

Authors:  P A Löschmann; L A Smith; K W Lange; P Jaehnig; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.

Authors:  K K Gnanalingham; A J Hunter; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

3.  Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset.

Authors:  K K Gnanalingham; D D Erol; A J Hunter; L A Smith; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.